Bae et al. showed that CSNK2A1 and SIRT6 are indicators of poor prognosis in breast cancer and that CSNK2A1-mediated phosphorylation of SIRT6 could be involved in the progression of breast cancer [38]. Here, SIRT6 is linked to breast carcinoma.